Disorders of Nucleotide Expansion and Splicing 2 Flashcards

1
Q

Spinal Muscular Atrophy normal vs. pathologic

A

Have 2 SMN genes with identical AA sequences - normal

Deletion of SMN1, leaving only SMN2 active

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Severity of SMA releated to

A

AMount of exon 7 conatined in SMN portein

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

SMA mutation

A

T for C in exon 7 of SMN1…causes omission of exon 7…changes ESE to ESS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Role of SMN in the cell

A

Assembly of snRNPs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

DMD mutation

A

A for T in exon 31 of dystrophin…causes omission of exon 31…creates stop codon and ESS signal…sometimes exon including stop codon is skipped so the protein is mildly functional vs. truncated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Frontal temporal dementia with parkinsonism mutation

A

Normally 4R tau=3R tau

Amplication of ESE in exon 10 of MAPT (chromosome 17)…leads to more 4R tau and less 3R tau

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

CF mutation

A

most commonly exon 10 deletion of phenylalanine…changes in number of

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

CF exon 9 inclusion

A

Affects phenotype expressivity…mild disease if exon 9 present, severe if absent…determined by (UG)m(U)n

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Antisense oligonucleotide tx

A

Bind to target ESS and conjugated to proteins containing an ESE element. Basically replace a silencer with an enhancer…encourages retention of desired exon in final transcript.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

snRNAs as vehicle for antisense RNA

A

Will cause skipping of stop codon exon…leads to partially functional

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

RNAi will

A

Degrade the protein

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Hairpins drive

A

Expansions and contractions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Mechanism of DM1

A

CUG repeat expansion in the 3’UTR of the DMPK gene…causes formation that sequester MBNL1 and upregulates CELF1 (a CUG binding protein)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

MIssplicing examples in myotonic dystrophy

A

Missplicing of CLCN1 results in NMD and IR alpha missplicing causes insulin resistance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Accumulations of DM

A

Are in the nucleus composed of proteins and mRNA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Spinocerebellar ataxia 8 mutation

A

CTG expansion in noncoding RNA

17
Q

Mechanism of SCA8

A

Antisense transcript to CTG becomes polyglutamine repeats that accumulate in the cerebellum

18
Q

Sequestrian hypothesis

A

Normal binding proteins such as MBNL1 that help splicing are sequestered to hairpin structures and prevents them from working on regular proteins

19
Q

Over expression of MBNL

A

Rescues phenotypes of DM

20
Q

DMPK protein is a

A

protein kinase

21
Q

Cis effects of DM1

A

Haploinsufficiency due to less DMPK protein…local disruption of chromatin…dz is mostly trans-dominant

22
Q

FXTAS mutation

A

In FMR1 mRNA with CGG repeats

23
Q

FXTAS sources of toxicity

A

1) Sequestration of RNA binding proteins

2) Irregular translation of short peptides that are toxic

24
Q

FXTAS DNA repair

A

DNA damage repair is overtaxed and therefore not as effective

25
Q

ALS haploinsufficiency

A

Reduced expression of a given gene

26
Q

Gain of function ALS

A

Formation of aggregates of RNA and sequestering of proteins

27
Q

ALS also has

A

Abnormal bidirectional transcription of the expanded repeat sequences followed by RAN translation into dipeptide protein repeat proteins (DPRs)

28
Q

Therapeutic targets

A

1) MBNL1 overexpression via adenovirus
2) PKC inhibition via hyperphosphorylation of CELF1
3) Toxic RNA silencing using siRNA or ASOs to create degradation
4) Toxic RNA targeted for binding to eliminate ineraction with RNA binding proteins or small molecules using ASOs
5) Toxic RNA bound by small molecules to induce relaxation and release MBNL1

29
Q

Trans-dominant disorders

A

Controls expression of a gene on another chromosome

30
Q

Cis-dominant disorders

A

Where gene activity affected in same chromosome of mutation

31
Q

DM1 loss and gain of function

A

Loss - MBNL1

Gain - CELF1